SPP-037
Product Specifications
Target
Endogenous Metabolite, FAK
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis, Metabolism, Cytoskeletal Signaling
Bioactivity
SPP-037 is an orally active selective inhibitor of ST6GAL1, with an IC50 of 3.59 μM. It exhibits anti-migration activity against MDA-MB-231 cells by inhibiting integrin α2,6-sialylation and the integrin-FAK-paxillin pathway. In MDA-MB-231 xenograft mouse models, SPP-037 demonstrates antitumor properties. This compound is applicable in breast cancer research.
Molecular Formula
C36H50ClN3O9S
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV639891 1.0 µg DNA
PPM1K Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details 
MBS2553932-01 0.025 mg
Anti-Rat CD4 (domain 1 Conjugated) Monoclonal Antibody (Biotin Conjugated)
Sign In for Pricing
View Details MBS2553932-02 0.1 mg
Anti-Rat CD4 (domain 1 Conjugated) Monoclonal Antibody (Biotin Conjugated)
Sign In for Pricing
View Details MBS2553932-03 5x 0.1 mg
Anti-Rat CD4 (domain 1 Conjugated) Monoclonal Antibody (Biotin Conjugated)
Sign In for Pricing
View Details 
orb1179051-01 5 µg
Recombinant IL-30 (Interleukin-30), Human, Animal-Free
Sign In for Pricing
View Details